Mela Osorio, Marķa J <br/><br/>
Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status.  [electronic resource] 

 -  European journal of haematology  Apr 2016 
 - 435-42 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/ejh.12614  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anemia--etiology<br/>Calreticulin--genetics<br/>Child<br/>Female<br/>Follow-Up Studies<br/>Gene Expression<br/>Humans<br/>Janus Kinase 2--genetics<br/>Male<br/>Middle Aged<br/>Mutation<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Primary Myelofibrosis--etiology<br/>Quinazolines--administration & dosage<br/>Receptors, Thrombopoietin--genetics<br/>Retrospective Studies<br/>Thrombocythemia, Essential--drug therapy